| Literature DB >> 34212072 |
Na Sun1, Yi-Te Lee1, Minhyung Kim2, Jasmine J Wang2, Ceng Zhang1, Pai-Chi Teng2, Dongping Qi1, Ryan Y Zhang1, Benjamin V Tran3, Yue Tung Lee1, Jinglei Ye1, Juvelyn Palomique4, Nicholas N Nissen4, Steven-Huy B Han3, Saeed Sadeghi3, Richard S Finn3, Sammy Saab3, Ronald W Busuttil3, Edwin M Posadas2, Li Liang5, Renjun Pei6, Ju Dong Yang4, Sungyong You2, Vatche G Agopian3, Hsian-Rong Tseng1, Yazhen Zhu1.
Abstract
Transcriptomic profiling of tumor tissues introduces a large database, which has led to improvements in the ability of cancer diagnosis, treatment, and prevention. However, performing tumor transcriptomic profiling in the clinical setting is very challenging since the procurement of tumor tissues is inherently limited by invasive sampling procedures. Here, we demonstrated the feasibility of purifying hepatocellular carcinoma (HCC) circulating tumor cells (CTCs) from clinical patient samples with improved molecular integrity using Click Chips in conjunction with a multimarker antibody cocktail. The purified CTCs were then subjected to mRNA profiling by NanoString nCounter platform, targeting 64 HCC-specific genes, which were generated from an integrated data analysis framework with 8 tissue-based prognostic gene signatures from 7 publicly available HCC transcriptomic studies. After bioinformatics analysis and comparison, the HCC CTC-derived gene signatures showed high concordance with HCC tissue-derived gene signatures from TCGA database, suggesting that HCC CTCs purified by Click Chips could enable the translation of HCC tissue molecular profiling into a noninvasive setting.Entities:
Keywords: circulating tumor cells; click chemistry; hepatocellular carcinoma; nanosubstrate; transcriptome profiling
Year: 2021 PMID: 34212072 PMCID: PMC8240468 DOI: 10.1002/admt.202001056
Source DB: PubMed Journal: Adv Mater Technol